Chronic pain after total knee arthroplasty

  • Vikki Wylde
    Musculoskeletal Research Unit, Bristol Medical School, University of Bristol, UK.
  • Andrew Beswick
    Musculoskeletal Research Unit, Bristol Medical School, University of Bristol, UK.
  • Julie Bruce
    Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, UK.
  • Ashley Blom
    Musculoskeletal Research Unit, Bristol Medical School, University of Bristol, UK.
  • Nicholas Howells
    North Bristol NHS Trust, Southmead Hospital, Bristol, UK.
  • Rachael Gooberman-Hill
    Musculoskeletal Research Unit, Bristol Medical School, University of Bristol, UK.

抄録

<jats:p> Despite a good outcome for many patients, approximately 20% of patients experience chronic pain after total knee arthroplasty (TKA). Chronic pain after TKA can affect all dimensions of health-related quality of life, and is associated with functional limitations, pain-related distress, depression, poorer general health and social isolation. In both clinical and research settings, the approach to assessing chronic pain after TKA needs to be in-depth and multidimensional to understand the characteristics and impact of this pain. Assessment of this pain has been inadequate in the past, but there are encouraging trends for increased use of validated patient-reported outcome measures. Risk factors for chronic pain after TKA can be considered as those present before surgery, intraoperatively or in the acute postoperative period. Knowledge of risk factors is important to guide the development of interventions and to help to target care. Evaluations of preoperative interventions which optimize pain management and general health around the time of surgery are needed. The causes of chronic pain after TKA are not yet fully understood, although research interest is growing and it is evident that this pain has a multifactorial aetiology, with a wide range of possible biological, surgical and psychosocial factors that can influence pain outcomes. Treatment of chronic pain after TKA is challenging, and evaluation of combined treatments and individually targeted treatments matched to patient characteristics is advocated. To ensure that optimal care is provided to patients, the clinical- and cost-effectiveness of multidisciplinary and individualized interventions should be evaluated. </jats:p><jats:p> Cite this article: EFORT Open Rev 2018;3:461-470. DOI: 10.1302/2058-5241.3.180004 </jats:p>

収録刊行物

被引用文献 (2)*注記

もっと見る

問題の指摘

ページトップへ